Navigation Links
News Release: Conventus Launches Webinar Series on Pain Management Regulations

Conventus, New Jersey’s premier professional liability insurer formed by and governed through an alliance of independent physicians, has launched a new educational series of webinars and podcasts to guide medical practices on understanding and complying with New Jersey’s new regulations governing the prescribing of pain medication. The first two episodes of the series, entitled “Pain Management and Opioids: New Laws, Regulations & Strategies,” will be available to ALL New Jersey physicians and their practices.

With the opioid abuse epidemic reaching crisis levels in New Jersey, the state legislature passed strict new regulations in 2017 governing the prescribing of opioid painkillers and other narcotics for the treatment of pain. Conventus created this series of webinars and podcasts to guide medical practices on understanding and complying with these new rules. The series is presented by Susan Lieberman, Conventus’ Vice President of Practice Resources.

“It is crucial that New Jersey physicians understand these new regulations, and how they affect both their patients and their practice,” Lieberman said. “Disciplinary actions in 2016 resulted in 31 New Jersey physicians being sanctioned for over-prescribing painkillers and other narcotics. Eight lost their licenses. The new regulations have very strict rules around initial opioid prescriptions, participation in the New Jersey Prescription Monitoring Program, and much more. Our goal with this series is to break down these complex new regulations into clear, easy to understand language and guidance that physicians and their practices can use.”

This series provides education and guidance vital to NJ medical practices using short, 10-15 minute episodes designed to fit their busy schedule. They are also available as audio-only podcasts, so they can listen on their way to or from the office. The first two episodes of this series are available now for all New Jersey physicians and the members of their practice.

Topics include:

  •     An Overview of the New Regulations and Strategies for Your Practice *Available NOW
  •     Informed Consent and Pain Management *Available NOW
  •     The New Jersey Prescription Monitoring Program
  •     Documentation
  •     Treatment Planning
  •     Prescription Practices
  •     Management of Acute and Chronic Pain

To view the webinars or listen to the podcasts, visit

About Conventus Inter-Insurance Exchange
As New Jersey’s premier professional liability insurer formed by and governed through an alliance of physicians, Conventus is devoted to serving the best interests of independent physician practices.

Conventus members and their staff enjoy exclusive access to insurance products and highly personalized services, gaining the practical knowledge and expert resources they need to improve practice performance, better serve their patients, and remain independent. The Conventus team prides itself on being forward lookers and solution partners whose sole purpose is to help independent physician practices thrive in today’s rapidly changing healthcare environment. Learn more at

Follow Conventus on Twitter @ConventusNJ and LinkedIn at Conventus Inter-Insurance Exchange

Read the full story at

Source: PRWeb
Copyright©2017 Vocus, Inc.
All rights reserved

Related medicine news :

1. Video Release: NovuHealth on Medicare Customer Engagement to Boost Star Quality Ratings
2. Video Release: NovuHealth on Medicare Customer Engagement and Quality Score Improvement
3. For Immediate Release: Tri Sirena Launches Their First Sun Protective Performance Gear w/ SPF 50
4. New Video Release: Jason Feruggia’s Interview with Personal Trainer Marketing Expert Bedros Keuilian
5. New Release: STAR-CD and es-ice v4.22
6. Conventus to Host Live Webinar on MACRA’s Quality Payment Program for Medical Practices
7. Conventus to Exhibit at NJMGMA 2015 Practice Management Conference April 30th - May 1st
8. Evergreen Healthcare Partners Launches Talent Management Solutions
9. MedMatchPlus+ Launches New Residency Application Supplemental Tool for Medical Students
10. Global Lyme Alliance Launches "Be Tick Aware" Program
11. PCAB Launches USP 800-based Distinction in Hazardous Drug Handling (HDH)
Post Your Comments:
(Date:10/13/2017)... ... 13, 2017 , ... “America On The Brink”: the Christian history of the ... is the creation of published author, William Nowers. Captain Nowers and his wife, ... he spent thirty years in the Navy. Following his career as a naval ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... the demand of today’s consumer and regulatory authorities worldwide. From Children’s to Adults ... tested to meet the highest standard. , These products are also: Gluten ...
(Date:10/12/2017)... , ... October 12, 2017 , ... ... delivery system that we intend to develop to enable prevention of a major ... to severe hearing loss, especially in pediatric patients. For cisplatin, hearing loss is ...
(Date:10/12/2017)... ... October 12, 2017 , ... On Saturday, October 21, the ... – Miles by Moonlight to raise money for the American Heart Association Heart Walk. ... , Teams will work together to keep their treadmills moving for 5 hours. Treadmills ...
(Date:10/12/2017)... Miramar, FL (PRWEB) , ... October 12, 2017 ... ... is presenting the latest in wound care advancements to physician colleagues, skilled nursing ... lecture is titled, "Navigating the Treacherous Waters of Wound Care." , "At many ...
Breaking Medicine News(10 mins):
(Date:9/28/2017)... 28, 2017 Hill-Rom Holdings, Inc. (NYSE: HRC), ... call and webcast on Friday, November 3, 2017, beginning ... ending at approximately 8:30 a.m. (CDT) / 9:30 a.m. ... 2017 financial performance and guidance for 2018, Hill-Rom executives ... enhance operational performance, and long-range financial outlook through 2020. ...
(Date:9/27/2017)... , Sept. 27, 2017  DarioHealth Corp. (NASDAQ: DRIO), a leading ... announced that its MyDario product is expected to appear on The Dr. ... The Dr. Oz Show airs in your area: ... The nine-time Emmy award-winning, The Dr. Oz Show ... The segment ...
(Date:9/23/2017)... -- Janssen Biotech, Inc. (Janssen) announced today that it ... Food and Drug Administration (FDA) for the Biologics License ... of moderately to severely active rheumatoid arthritis (RA). The ... to further evaluate the safety of sirukumab in the ... "We are disappointed by ...
Breaking Medicine Technology: